DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pentastarch is an investigational drug.
There have been 5 clinical trials for Pentastarch. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Shock, Shock, Traumatic, and Shock, Hemorrhagic. The leading clinical trial sponsors are Sangart, University of British Columbia, and Children's & Women's Health Centre of British Columbia.
Recent Clinical Trials for Pentastarch
|Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients||Sangart||Phase 2|
|Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients||Sangart||Phase 2|
|Fluid Resuscitation in Early Septic Shock||Baxter Healthcare Corporation||Phase 2|